SCHOENBERG MARK (Chief Medical Officer) sold 50.7% of their position (60.68K shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $2.85M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/24/2026ACC: 0001437749-26-028840
Officer· Chief Medical Officer
Since Jan 2019
-60.68K
Net shares
Net seller
$2.85M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
60.68K disposed
Non-Derivative Transactions1
ordinary shares
Direct
Shares
−60.68K
Price / share
$47.05
Trade value
$2.85M
% of position
50.7%
8/20/2026
119.76K→59.09K
Total
Net shares
−60.68K
Net value
-$2.85M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| ordinary shares Direct | 8/20/2026 | S · Sale | −60.68K | $47.05 | $2.85M | 50.7% | 119.76K | 59.09K |
| Total | −60.68K | -$2.85M | ||||||
Derivative Transactions0
No derivative transactions reported